EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure

AstraZeneca turned heads with data showing Farxiga could improve heart failure outcomes for people with and without diabetes. Now, it's out with positive metabolic and safety data that further support Farxiga use in nondiabetic patients.